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Introduction In the first half of the 20th century, while the value of translating scientific discovery to clinical care was
clearly established, the pace of innovation was resulting in increased specialization in both medicine and science — and
increased duration of their respective training paths. In the 1950s and 1960s, American doctors were drafted to serve in
the Korean and Vietnam Wars (1). In 1953, the National Institutes of Health (NIH) started its Associate Training Program,
which selected physicians who applied to the US Public Health Service Commissioned Corps to serve as clinical
associates at the NIH (2). Associates were allowed to pursue mentored research training at the NIH and a unique
opportunity for physician-scientist training emerged (3). In 1956, the NIH launched its Experimental Training Program to
provide medical students with opportunities for summer research experiences or additional years of training focused on
research (4). Such programs have produced leading scientists, including several Nobel Prize laureates, members of the
National Academy of Sciences, and directors and institute directors at the NIH (1). Individual medical schools began
offering combined MD-PhD training in the 1950s, and in 1964, the National Institute of General Medical Sciences
(NIGMS) launched the Medical Scientist Training Program (MSTP) to facilitate MD-PhD dual-degree training programs
(4). MSTP graduates are well represented in academia (4); yet, they comprise […]
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Introduction
In the first half of the 20th century, while 
the value of translating scientific discov-
ery to clinical care was clearly established, 
the pace of innovation was resulting in 
increased specialization in both medicine 
and science — and increased duration 
of their respective training paths. In the 
1950s and 1960s, American doctors were 
drafted to serve in the Korean and Vietnam 
Wars (1). In 1953, the National Institutes of 
Health (NIH) started its Associate Train-
ing Program, which selected physicians 
who applied to the US Public Health Ser-
vice Commissioned Corps to serve as clin-
ical associates at the NIH (2). Associates 
were allowed to pursue mentored research 
training at the NIH and a unique oppor-
tunity for physician-scientist training 
emerged (3). In 1956, the NIH launched its 
Experimental Training Program to provide 
medical students with opportunities for 
summer research experiences or addition-
al years of training focused on research 
(4). Such programs have produced leading 
scientists, including several Nobel Prize 
laureates, members of the National Acade-
my of Sciences, and directors and institute 
directors at the NIH (1).
Individual medical schools began 
offering combined MD-PhD training 
in the 1950s, and in 1964, the Nation-
al Institute of General Medical Sciences 
(NIGMS) launched the Medical Scientist 
Training Program (MSTP) to facilitate 
MD-PhD dual-degree training programs 
(4). MSTP graduates are well represent-
ed in academia (4); yet, they comprise a 
small pool of talent and the total num-
ber of physicians engaged in research in 
the United States continues to diminish. 
While 41,178 research doctorate degrees 
were conferred in science and engineer-
ing fields in the United States in 2016 (5), 
only about 600 dual-degree MD-PhD 
students are graduated annually (6). The 
much larger pool of MD-only graduates 
(approximately 20,000 annually) there-
fore represents untapped potential to sub-
stantially increase the number of physi-
cians engaged in research. However, most 
US MD programs focus on clinical training 
without a research component.
Accordingly, the Burroughs Wellcome 
Fund (BWF) launched an initiative in 
2017 to develop a new cadre of MD-only 
physician-scientists by addressing barri-
ers particular to them. The BWF Physi-
cian-Scientist Training Initiative infused 
$25 million in flexible Physician-Scientist 
Institutional Awards (PSIAs), granted to 
ten medical schools who proposed inno-
vative approaches to MD-only physician- 
scientist development. For the purposes 
of this initiative, “physician-scientist” is 
defined as a medical student or physician 
(MD, DO, or equivalent) actively engaged 
in laboratory-based discovery science.
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establishing effective communication 
strategies for recruitment and promotion.
Implementation barriers. Programs 
intending to offer preferred admission 
to next-stage training (i.e., residency or 
fellowship physician-scientist training 
programs [PSTPs]) at times discovered 
challenges with the match process that 
precluded a strategic transition. Further-
more, programs found that Graduate 
Medical Education policies or time and 
resource constraints might limit support 
of research-in-residency opportunities 
for patient-oriented discovery science. 
Practical challenges included limitations 
in accessibility and quality of institution-
al data on students, trainees, and faculty 
needed to identify the target audience for 
PSIA initiatives; as well as the substantial 
time required to organize infrastructure, 
hire staff, and promote acceptance of pro-
grams by participants.
Lessons learned. To develop the resil-
ience required to simultaneously master 
medicine and science, camaraderie is 
key. PSIA grantees have established men-
torship teams, peer networks, advanced 
career development content, and execu-
tive coaching to this end. Compensation 
for mentor effort offers an approach to 
incentivize participation. The provision 
of financial and human resources (e.g., 
technician support) facilitates difficult 
transitions between research and clinical 
training. Vertical integration across the 
physician-scientist community contrib-
utes to promoting program engagement, 
visibility, and retention across training and 
career transitions. Careful coordination 
and communication with administrators 
and regulatory and accreditation bodies 
— and across existing programs and infra-
structure — is necessary both to promote 
buy-in and to navigate potential political 
sensitivities or territoriality.
Institutional changes. All ten PSIA 
grantees launched substantial organiza-
tional changes, with the development of 
new centralized divisions or offices that 
serve as “home” for physician-scientists; 
new associate dean or other leadership 
positions; and/or new curriculum, tracks, 
or Master’s and certificate programs in 
medical school training, residency, or fel-
lowship programs.
National-level changes. Efforts and ear-
ly outcomes of PSIA programs and projects 
al approaches to supporting physician-sci-
entist development. Institutional support 
includes funds provided by schools and 
health systems, Deans’ offices, and depart-
ments; administrative (staff and faculty 
leadership) support; funding for specific 
programmatic activities; philanthropic 
gifts; and commitments to sustain support 
at the conclusion of the funding period.
Diversity, equity, and inclusion. PSIA 
grantees report dedication to serving 
diverse constituencies and addressing 
the systemic racism that has perpetu-
ated underrepresentation and inequity. 
All programs are collecting participant 
demographic information. Most are also 
collecting information on disability and 
disadvantaged-background status. At this 
early time point, one-third of PSIA pro-
grams reported that less than 10% of their 
participants were from racial and ethnic 
populations underrepresented in medicine 
(URiM) backgrounds, one-third reported 
between 10% and 25%, and the remain-
der reported between 26% and 50% par-
ticipants from URiM backgrounds. In 
two-thirds of programs, women made up 
51%–75% of participants, and one-third 
reported that 25%–50% of their partici-
pants are female.
Approaches to enhance diversity, 
equity, and inclusion have included work-
shops and trainings, formal integration of 
diversity and inclusion leadership in pro-
gram teams, and assessment of program-
matic reach to URiM individuals. Because 
individuals from URiM backgrounds and 
women are poorly represented at senior 
faculty and leadership levels, diversity 
among potential mentors is limited. PSIA 
grantees report leveraging peer and “near-
peer” mentorship for enhanced diversity 
among role models, providing culturally 
aware mentor training, and investing in 
long-term strategies to increase diversi-
ty in the physician-scientist pipeline by 
focusing on programs and activities that 
provide early exposure to the career path.
Program implementation
All PSIA institutions established a new 
administrative office or other structure 
to coordinate programs, which included 
hiring staff and establishing leadership 
positions, securing mentors and research 
preceptors, raising matching funds, devel-
oping evaluation and tracking tools; and 
The BWF identified several common 
barriers to physician-scientist training: (a) 
lack of mentoring/role models, (b) lack of 
structured research training/experience 
in discovery science, (c) financial pres-
sures and debt, (d) limited administrative 
support/centralized structure for physi-
cian-scientist training pathways, (e) bur-
den of clinical training/responsibilities, 
and (f) career–personal life balance (7). 
Based on institutional support, commit-
ment to diversity, scalability, and longitu-
dinal evaluation plan, BWF awarded PSIA 
grants to ten institutions: Duke University 
(8), Stanford University (9), University of 
Pittsburgh (10), University of Texas South-
western Medical Center (11), Vanderbilt 
University (12), Texas A&M University 
(13), UCLA (14), University of Chicago 
(15), Washington University (16), and Weill 
Cornell Medicine (17). The five-year, $2.5 
million grants support development, test-
ing, evaluating, disseminating, and sus-
taining novel approaches that address the 
barriers to physician-scientist training, 
with the ultimate goal of developing a new 
generation of physician-scientists who 
advance biomedical discovery to improve 
human health.
Description and administration 
of programs
Summary and categories of institutional 
approaches. PSIA institutions have imple-
mented their programs (Figure 1) , featur-
ing many common elements. Individual 
approaches include structured education/
training/professional development; fund-
ing opportunities (for research support, 
tuition, or personal life use); integrated 
research training programs; mentorship; 
and new degree and certificate programs. 
Many programs feature distinctive ele-
ments, including networking and commu-
nity building, connections with regional 
experts and infrastructure, and leadership 
training. Collectively, PSIA programs 
serve medical students, residents, fellows, 
instructors, and early-career faculty — with 
some targeting a single vulnerable group 
and others addressing the entire pipeline.
Institutional support. Institutional sup-
port provides avenues for sustainability of 
effective approaches. All PSIA grantees 
indicated institutional matching funds and 
leveraging/consolidation of preexisting 
programs for more centralized institution-
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and engineering curriculum has been 
established at a PSIA institution, providing 
a model for similar approaches. Buttressed 
by their organizational infrastructures, 
PSIA grantees have successfully compet-
lish an MD-only program that supports 
a gap year for research (18). Additionally, 
the first Association of American Medical 
Colleges Liaison Committee on Medical 
Education–approved integrated medicine 
have begun to influence the landscape of 
physician-scientist training at a national 
level. For example, a new nonprofit orga-
nization, the Physician Scientist Support 
Foundation, is working nationally to estab-
Figure 1. PSIA-funded programs, approaches, and career stage targets. PSIA institutions completed a survey to catalog and compare categorical key 
approaches across institutions as well as the targeted career stage by program. Key approaches were categorized and approaches newly launched with the 
PSIA are indicated with black-filled circles. Those that were preexisting at an awardee institution, but incorporated into the PSIA program, are indicated 
with gray-filled circles. Approaches that were preexisting and not incorporated into the PSIA program are indicated with open circles. Career stage targets 
by program are indicated with blue-filled circles.
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it is critical that they not increase the sub-
stantial debt burden that faces medical 
students. Collective investment by feder-
al funding programs, institutions, health 
systems, and philanthropy will be crucial 
for successful execution of MD research 
training programs.
We anticipate the PSIA efforts — com-
bined with necessary policy changes at 
the institutional and national levels — will 
effectively lower the hurdles to estab-
lishing academic careers and ultimately 
change the view of medical school, res-
idency, and fellowship to an environ-
ment that supports generating physician- 
scientists throughout the career pipeline. 
In turn, this investment will increase the 
number of physician-scientists leading 
successful research careers.
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grams will evaluate their sustainability, 
the number of physician-scientists enter-
ing and remaining in the career path, and 
research breakthroughs discovered by 
MD-only physician-scientists.
Summary and anticipated 
impact
Collectively, the PSIA grantee institutions 
are conducting ten different experiments. 
Through these efforts, we aim to identify 
and define key financial and nonfinancial 
factors and resources needed to create a 
longitudinally structured and continuous 
immersive training path to professional 
independence. Successful elements of the 
ten PSIA experiments will broaden acces-
sibility of the physician-scientist career 
path to different clinical disciplines and 
demographic populations. Establishment 
of a national network of PSIA programs 
and formalized relationships with other 
institutions will continue multidisciplinary 
support and mentorship for trainees, 
with each serving as a hub for developing 
expanded regional collaboratives for phy-
sician-scientist training.
Barriers to the successful pursuit of 
MD-only research careers persist at insti-
tutional and national levels and must be 
addressed in order to develop a critical 
mass of physician-scientists in the bio-
medical workforce. The institutional clas-
sification of trainees during research years 
may affect compensation and access to 
low-cost health insurance. Institutions are 
increasingly relying on clinical educator 
faculty, resulting in limited interactions 
for medical students with physician-sci-
entists. Medical students are encouraged 
to seek opportunities for higher quantities 
of publications in order to compete for res-
idency, dissuading their pursuit of discov-
ery science experiences. At the national 
level, the Accreditation Council for Gradu-
ate Medical Education (ACGME) require-
ments for quality improvement activities 
during training have limited consideration 
of laboratory-based research opportunities 
among residents.
MD research opportunities can be 
expanded through changes to medical 
school curricula, summer research train-
ing opportunities, and postgraduate phy-
sician-scientist training programs that 
integrate research and clinical training. 
To support access to these opportunities, 
ed for a large share (7 of 21) of the NIH 
Stimulating Access to Research in Resi-
dency R38 pilot awards granted to date. In 
turn, several national medical boards have 
approved an R38 pathway for research in 
residency at multiple institutions.
Traditional metrics. PSIA grantees are 
tracking the outcomes of program partici-
pants to gauge success. All grantees intend 
to compare their program participants to 
MD-PhD students, baseline, or nonpar-
ticipants and to follow metrics of scholarly 
output (grant applications/success, pub-
lications/impact factors, presentations, 
honors and awards, patents/licenses) 
and career progression, as appropriate 
for the stage of intervention. Additional-
ly, all programs are tracking attendance/
enrollment, matriculation, attrition, and 
demographics of participants. PSIA grant-
ees also report plans to assess the level of 
engagement of participants, satisfaction 
with programs and mentors, and long-
term career plans via survey instruments.
Nontraditional metrics. Individual PSIA 
grantees have identified various plans to 
track nontraditional metrics, including the 
following validated tools: resilience/grit 
scale, intrinsic/extrinsic motivation scale, 
career adaptabilities scale, burnout scale, 
and career/life satisfaction scale. Oth-
er unique metrics planned for evaluation 
include surveys to assess perceived self- 
efficacy in research and mentoring rela-
tionships; and a survey tool called Diag-
nostic Assessment of Research Training 
Strengths that will identify real and per-
ceived barriers to MD-based research 
careers at different stages of training; better 
identify the personal training and mentor-
ing needs of incoming trainees; and identi-
fy features of research training support that 
may differ between men, women, and/or 
individuals from URiM backgrounds.
Additional metrics will include 
resource utilization and impact at differ-
ent career stages; curriculum evaluation; 
interdisciplinary faculty evaluation, train-
ee self-assessment, and peer assessment; 
confidence in self-efficacy and research 
efficacy; and personal identity essays. Sur-
veys of mentors will identify challenges 
of senior faculty and ways to incentivize 
mentoring. For PSIA grantees focused 
on medical students, a unique metric will 
be to track those who enter a residency 
program at another PSIA institution. Pro-
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